The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial

BACKGROUND: Acute administration of the oral 5-HT(1)A receptor agonist buspirone, which is commonly used as an anxiolytic drug, may improve compromised lower esophageal sphincter function. In an open-label trial we assessed the effects of buspirone on esophageal motor function and symptoms in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamanolis, George P., Panopoulos, Stylianos, Denaxas, Konstantinos, Karlaftis, Anastasios, Zorbala, Alexandra, Kamberoglou, Dimitrios, Ladas, Spiros D., Sfikakis, Petros P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009650/
https://www.ncbi.nlm.nih.gov/pubmed/27586891
http://dx.doi.org/10.1186/s13075-016-1094-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009650/
https://www.ncbi.nlm.nih.gov/pubmed/27586891
http://dx.doi.org/10.1186/s13075-016-1094-y

Ejemplares similares